Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chylothorax].

Marc Riquet1, Françoise Le Pimpec Barthes, Alain Badia

  • 1Service de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, 20, rue Leblanc, 75908 Paris, France. marc.riquet@hop.egp.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|May 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Geographical Deprivation Index is Independently Associated With All-Cause Long-Term Mortality in Resectable Lung Cancer.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

Beyond Body Mass Index: The Impact of Height and Height-Normalised Weight on Overall Survival of Lung Cancer Undergoing Surgery.

Journal of cachexia, sarcopenia and muscle·2025
Same author

Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.

Thorax·2024
Same author

Impact of surgical approach on 90-day mortality after lung resection for nonsmall cell lung cancer in high-risk operable patients.

ERJ open research·2024
Same author

Middle lobe suffering due to malposition and 180° tilt of the 2 remaining lobes after right upper lobectomy.

Interdisciplinary cardiovascular and thoracic surgery·2023
Same author

Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: A French nationwide study from the Epithor cohort database.

The Lancet regional health. Europe·2023

Chylothorax, the presence of chyle in the chest, results from thoracic duct lesions. Treatment involves dietary changes and potentially surgery, leading to effusion regression.

Area of Science:

  • Physiology
  • Thoracic Medicine

Context:

  • Chylothorax is defined as the intrathoracic accumulation of chyle, a lipid-rich lymph originating from the intestines.
  • Chyle travels to the bloodstream via the thoracic duct, which collects lymphatic drainage from below the diaphragm, the diaphragm itself, and the sternocostal wall.

Purpose:

  • To explain the pathophysiology of chylothorax, involving lesions of the thoracic duct or its tributaries.
  • To outline diagnostic approaches, such as pedal lymphography for anatomical clarification.
  • To detail therapeutic strategies for managing chylothorax.

Summary:

  • Chylothorax arises from acquired or spontaneous thoracic duct damage, potentially causing chyle reflux due to collateral vessel incontinence.
  • Medical management includes nutritional support and a fat-restricted diet with medium-chain triglycerides.

Related Experiment Videos

  • Surgical options encompass pleural symphysis, collateral vessel repair, or thoracic duct ligation, with indications based on chyle leakage severity and lesion type.

    • Impact:

    • Effective treatment, whether medical or surgical, typically leads to the resolution of pleural effusion.
    • Understanding the etiology and clinical course is crucial for selecting appropriate therapeutic interventions.
    • This comprehensive approach ensures favorable outcomes in nearly all chylothorax cases.